BRCA2 and cancer: The BRCA1 and BRCA2 genes encode proteins involved in double-stranded DNA break repair; thus, BRCA mutation-associated cancers may be more sensitive to chemotherapeutic agents that cause DNA damage, such as platinum-based agents [11,12,13,14].